在中风患者中使用口服抗凝剂:基于当前实践指南的叙述性综述
1Department of Neurology, Himalayan Institute of Medical Sciences, Dehradun, Uttarakhand, India.
Brain circulation
|January 14, 2026
概括
本综述综合了关于预防中风的口服抗凝剂 (OAC) 的当前知识,比较维生素K对抗剂 (VKA) 与较新的非维生素K对抗剂口服抗凝剂 (NOAC). 它有助于临床医生选择合适的OAC,特别是在复杂的情况下.
科学领域:
- 心脏病学 心脏病学
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 脑卒中患者通常需要口服抗凝剂 (OAC) 来预防复发性血栓栓塞事件.
- 华法林 (一种维生素K对抗剂,VKA) 是传统的OAC,但新的非维生素K对抗剂口服抗凝剂 (NOAC) 提供了替代品.
- 广泛的文献和不断变化的指南需要进行全面的审查,以获得最佳的临床决策.
研究的目的:
- 提供关于OAC在中风预防中的使用现有发现和建议的叙述性综述.
- 为了比较VKA和NOAC,解决它们的疗效,安全性和在不同患者群体中的应用.
- 引导临床医生选择最适合中风患者的OAC,包括特殊人群和外科期间的管理.
主要方法:
- 文献综述和现有随机试验,元分析和临床指南的综合.
- 结构化审查涵盖VKA协议,心房的定义和OAC使用的建议.
- 专注于特殊人群,术后管理,以及针对亚洲人群的具体考虑.
主要成果:
- 有大量证据比较VKA和NOAC用于预防中风.
- 新兴的指导方针反映了OAC选择的转变,在许多场景中有利于NOAC.
- 确定缺乏明确指导的领域,特别是针对特定患者子组和亚洲人口的领域.
结论:
- 临床医生必须利用当前的知识和指导方针来选择适当的OAC来预防中风.
- 本综述旨在增强对OAC选择的理解并澄清临床决策.
- 强调需要在特定的临床灰色区域进行进一步的研究和更明确的指导.
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.1K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.1K
Venous Thrombosis III: Interprofessional Care
278
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
278
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.7K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.7K
Venous Thrombosis IV: Nursing Management
192
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
192
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.1K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.1K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
311
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
311


